Literature DB >> 4563045

1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.

S K Carter, F M Schabel, L E Broder, T P Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4563045     DOI： 10.1016/s0065-230x(08)60343-7

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  28 in total

1.  Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.

Authors:  Z P Chen; G Wang; Q Huang; Z F Sun; L Y Zhou; A D Wang; L C Panasci
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  [Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].

Authors:  H H Fiebig; D Schmähl
Journal:  Klin Wochenschr       Date:  1977-05-01

Review 3.  Cancer chemotherapy: new developments and changing concepts.

Authors:  S K Carter
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

4.  Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor.

Authors:  M Nagarkatti; P S Nagarkatti; A M Kaplan
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].

Authors:  T S Herman; B G Durie; J J Hutter
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits.

Authors:  C Ni; L H Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

7.  The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.

Authors:  P Bedford; M R Berger; G Eisenbrand; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  The nucleotide-permeable Escherichia coli cell, a sensitive DNA repair indicator for carcinogens, mutagens, and antitumor agents binding covalently to DNA.

Authors:  H W Thielmann; H Gersbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-09-28

9.  Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU).

Authors:  T Henne; M R Berger
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

10.  Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.

Authors:  W W Shih; R W Baumhefner; W W Tourtellotte; C M Haskell; E L Korn; J L Fahey
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.